메뉴 건너뛰기
Current Medical Research and Opinion
Volumn 23, Issue 10, 2007, Pages 2477-2483
Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs
Author keywords

Admixing; Arformoterol; Compatibility; HPLC analysis; Inhalation solution; Mixing
Indexed keywords

ACETYLCYSTEINE; ARFORMOTEROL TARTRATE; BROVANA; BUDESONIDE; IPRATROPIUM BROMIDE; PLACEBO; TARTARIC ACID DERIVATIVE; UNCLASSIFIED DRUG;
EID: 35648954113     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X233106     Document Type: Article
Times cited : (14)
References (7)
  • 1
    • 13544253826 scopus 로고    scopus 로고
    • Device selection and outcomes of aerosol therapy: Evidence-based guidelines. American College of Chest Physicians/American College of Asthma, Allergy, and Immunology
    • Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines. American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127:335-71
    • (2005) Chest , vol.127 , pp. 335-371
    • Dolovich, M.B.1    Ahrens, R.C.2    Hess, D.R.3
  • 2
    • 0038107379 scopus 로고    scopus 로고
    • GENEBU Project. Equipment and drugs used for home nebulizer therapy in Italy
    • Melani AS, Pirrelli M, Sestini P, et al. GENEBU Project. Equipment and drugs used for home nebulizer therapy in Italy. Monaldi Arch Chest Dis 2002;57:231-6
    • (2002) Monaldi Arch Chest Dis , vol.57 , pp. 231-236
    • Melani, A.S.1    Pirrelli, M.2    Sestini, P.3
  • 3
    • 18244421613 scopus 로고    scopus 로고
    • Home nebulizer use among patients with cystic fibrosis
    • Rosenfeld M, Emerson J, Astley S, et al. Home nebulizer use among patients with cystic fibrosis. J Pediatr 1998;132:125-31
    • (1998) J Pediatr , vol.132 , pp. 125-131
    • Rosenfeld, M.1    Emerson, J.2    Astley, S.3
  • 4
    • 2442637914 scopus 로고    scopus 로고
    • Compatibility of budesonide inhalation suspension with four nebulizing solutions
    • McKenzie JE, Cruz-Rivera M. Compatibility of budesonide inhalation suspension with four nebulizing solutions. Ann Pharmacother 2004;38:967-72
    • (2004) Ann Pharmacother , vol.38 , pp. 967-972
    • McKenzie, J.E.1    Cruz-Rivera, M.2
  • 5
    • 35648959774 scopus 로고    scopus 로고
    • Compatibility of levalbuterol inhalation solution mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium (Abstract)
    • McVicar W, Bonasia P, Ong S. Compatibility of levalbuterol inhalation solution mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium (Abstract). J Allergy Clin Immunol 2007;119:S1
    • (2007) J Allergy Clin Immunol , vol.119
    • McVicar, W.1    Bonasia, P.2    Ong, S.3
  • 6
    • 34347323745 scopus 로고    scopus 로고
    • Inhalation solutions: Which ones are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers
    • Kamin W, Schwabe A, Kramer I. Inhalation solutions: which ones are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers. J Cyst Fibros 2006;5:205-13
    • (2006) J Cyst Fibros , vol.5 , pp. 205-213
    • Kamin, W.1    Schwabe, A.2    Kramer, I.3
  • 7
    • 33846116201 scopus 로고    scopus 로고
    • Nebulized drug admixtures: Effect on aerosol characteristics and albuterol output
    • Berlinski A, Waldrep JC. Nebulized drug admixtures: effect on aerosol characteristics and albuterol output. J Aerosol Med 2006;19:484-90
    • (2006) J Aerosol Med , vol.19 , pp. 484-490
    • Berlinski, A.1    Waldrep, J.C.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.